Advances in primary thyroid lymphoma.
- Author:
Yuan LI
1
;
Ding-rong ZHONG
;
Quan-cai CUI
Author Information
1. Department of Pathology, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Lymphoma;
diagnosis;
pathology;
therapy;
Thyroid Neoplasms;
diagnosis;
pathology;
therapy
- From:
Acta Academiae Medicinae Sinicae
2006;28(5):724-729
- CountryChina
- Language:Chinese
-
Abstract:
Primary thyroid lymphomas (PTLs) are closely correlated with the autoimmune reaction of thyroid. However, the molecular mechanisms of PTLs are still unclear. It is really necessary to improve the ability to differentiate between benign and malignant PTLs along with the introduction of some new molecular biology methods. The diagnosis and prognosis of PTLs depend on their histological features, pathological classification, and clinical stages. Customized therapy of PTLs becomes possible with the further advances in lymphoma's pathological classification, clinical stages, and international prognosis index standard.
